MARA Holdings
MARA
MicroStrategy
MSTR
Tesla
TSLA
Coinbase
COIN
Amazon
AMZN
US Stock MarketDetailed Quotes
BMY Bristol-Myers Squibb
- 56.570
- +0.400+0.71%
Close Jan 3 16:00 ET
- 56.710
- +0.140+0.25%
Post 20:01 ET
114.73BMarket Cap-15.80P/E (TTM)
56.800High56.310Low9.53MVolume56.340Open56.170Pre Close539.60MTurnover0.47%Turnover Ratio14.66P/E (Static)2.03BShares60.41352wk High6.69P/B114.52BFloat Cap38.18252wk Low2.40Dividend TTM2.02BShs Float74.028Historical High4.24%Div YieldTTM0.87%Amplitude8.199Historical Low56.596Avg Price1Lot Size
About Bristol-Myers Squibb Company
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Company Profile
SymbolBMY
Company NameBristol-Myers Squibb
Listing DateJun 1, 1969
Issue Price40.50
Founded1933
CEODr. Christopher S. Boerner, PhD
MarketNYSE
Employees34100
Fiscal Year Ends12-31
AddressRoute 206 & Province Line Road
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08543
Phone1-609-252-4621
Websitehttp://www.bms.com
Company Executives
- Name
- Position
- Salary
- Dr. Christopher S. Boerner, PhD
- Chairman of the Board and Chief Executive Officer
- 8.46M
- Gregory Scott Meyers
- Executive Vice President, Chief Digital Officer and Chief Technology Officer
- --
- Dr. Robert M. Plenge
- Executive Vice President, Chief Research Officer and Head of Research
- --
- Dr. Samit Hirawat, M.D.
- Executive Vice President, Chief Medical Officer and Head of Development
- 6.23M
- Adam Lenkowsky
- Executive Vice President and Chief Commercialization Officer
- --
- David V. Elkins
- Executive Vice President and Chief Financial Officer
- 7.17M
- Amanda Ahn Poole
- Executive Vice President and Chief Human Resources Officer
- --
- Karin Shanahan
- Executive Vice President, Global Product Development and Supply
- --
- Phil Holzer
- Senior Vice President and Controller
- --
- Sandra Leung
- Executive Vice President and General Counsel
- 5.92M
- Cari Gallman
- Executive Vice President, Corporate Affairs
- --
- Lynelle Hoch
- President, Cell Therapy Organization
- --
- Dr. Manuel Hidalgo Medina, M.D.,PhD
- Independent Director
- 335.00K
- Dr. Deepak L. Bhatt, M.D.,M.P.H.
- Independent Director
- 329.97K
- Peter J. Arduini
- Independent Director
- 359.68K
- Dr. Karen H. Vousden, PhD
- Independent Director
- 344.74K
- Phyllis R. Yale
- Independent Director
- 365.00K
- Michael R. McMullen
- Independent Director
- --
- Paula A. Price
- Independent Director
- 365.00K
- Derica W. Rice
- Independent Director
- 375.00K
- Dr. Julia A. Haller, M.D.
- Independent Director
- 371.68K
- Theodore R. Samuels
- Lead Independent Director
- 425.00K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
